| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.063 | 0.3 |